×
Site Menu
Everything
International
Politics
Local
Finance
Sports
Entertainment
Lifestyle
Technology
Literature
Science
Health
Months after cancer drug trial, Merus agrees to be bought at 41% premium
4 months ago
21
ARTICLE AD BOX
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Read Entire Article
Homepage
Finance
Months after cancer drug trial, Merus agrees to be bought at 41% premium
Related
How a partial government shutdown this weekend would differ ...
32 minutes ago
0
Nvidia’s Campaign to Sell AI Chips to China Finally Pays Off...
48 minutes ago
0
The maid of honor won’t put expenses on her credit card for ...
1 hour ago
0
Trending
Popular
Can Pidcock win big & why did it end at Ineos?
11 months ago
504
‘I didn’t want to spend time with my children. I was just go...
11 months ago
463
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...
10 months ago
442
Netflix scuttles plans to add six previously announced games...
11 months ago
394
OpenAI co-founder John Schulman has left Anthropic after les...
11 months ago
349